Literature DB >> 9309095

Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.

J P Curtin1, F Shapiro.   

Abstract

While surgery is the primary treatment for the management of gynecologic malignancies, adjuvant chemotherapy and radiation therapy play a critical role in survival for many patients. In this article, we discuss the feasibility and effectiveness of adjuvant therapy for ovarian, cervical, and endometrial cancers, and discuss current recommendations.

Entities:  

Mesh：

Year:  1997        PMID： 9309095

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  3 in total

Review 1.  Adjuvant platinum-based chemotherapy for early stage cervical cancer.

Authors:  Daniela D Rosa; Lídia R F Medeiros; Maria I Edelweiss; Paula R Pohlmann; Airton T Stein
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 2.  Adjuvant platinum-based chemotherapy for early stage cervical cancer.

Authors:  Frederico S Falcetta; Lídia Rf Medeiros; Maria I Edelweiss; Paula R Pohlmann; Airton T Stein; Daniela D Rosa
Journal:  Cochrane Database Syst Rev       Date:  2016-11-22

3.  Peripherally Inserted Central Venous Catheters (PICC) versus totally implantable venous access device (PORT) for chemotherapy administration: a meta-analysis on gynecological cancer patients.

Authors:  Vito Andrea Capozzi; Luciano Monfardini; Giulio Sozzi; Giulia Armano; Diana Butera; Elisa Scarpelli; Giuseppe Barresi; Alessandro Benegiamo; Roberto Berretta
Journal:  Acta Biomed       Date:  2021-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.